Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal central motor function (HP:0011442)help
Parent Node:
expand
Abnormality of extrapyramidal motor function (HP:0002071)help
..Starting node
..expand
Bradykinesia (HP:0002067)help
Term ID: 2067
Name: Bradykinesia
Synonym: Slow movements; Slowness of movements
Definition: Bradykinesia literally means slow movement, and is used clinically to denote a slowness in the execution of movement (in contrast to hypokinesia, which is used to refer to slowness in the initiation of movement).
Comments:
Reference: HP:0002067
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAthetoid cerebral palsy (HP:0011445) help
..expandExaggerated startle response (HP:0002267) help
..expandExtrapyramidal dyskinesia (HP:0007308) help
..expandExtrapyramidal muscular rigidity (HP:0007076) help
..expandParkinsonism (HP:0001300) help
..expandProgressive extrapyramidal movement disorder (HP:0007153) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002067HP:0002067Bradykinesia0ACTA1 CL E G H58129ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent96
HP:0002067HP:0002067Bradykinesia0ADGRV1 CL E G H8405917416ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare530
HP:0002067HP:0002067Bradykinesia0ADH1C CL E G H126251OMIM:168600Parkinson disease, late-onset.4
HP:0002067HP:0002067Bradykinesia0ATL1 CL E G H5106211231ORPHA:100984Autosomal dominant spastic paraplegia type 3HP:0040284 - Very rare71
HP:0002067HP:0002067Bradykinesia0ATP13A2 CL E G H2340030213ORPHA:314632ATP13A2-related juvenile neuronal ceroid lipofuscinosisHP:0040282 - Frequent100
HP:0002067HP:0002067Bradykinesia0ATP13A2 CL E G H2340030213OMIM:606693Kufor-Rakeb syndrome100
HP:0002067HP:0002067Bradykinesia0ATP13A2 CL E G H2340030213ORPHA:306674Kufor-Rakeb syndromeHP:0040283 - Occasional100
HP:0002067HP:0002067Bradykinesia0ATP13A2 CL E G H2340030213OMIM:617225SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78100
HP:0002067HP:0002067Bradykinesia0ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss150
HP:0002067HP:0002067Bradykinesia0ATP1A3 CL E G H478801OMIM:128235Dystonia 12.150
HP:0002067HP:0002067Bradykinesia0ATP1A3 CL E G H478801ORPHA:71517Rapid-onset dystonia-parkinsonismHP:0040282 - Frequent150
HP:0002067HP:0002067Bradykinesia0ATP5MK CL E G H8483330889OMIM:618683MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6
HP:0002067HP:0002067Bradykinesia0ATP6AP2 CL E G H1015918305OMIM:300423MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH36
HP:0002067HP:0002067Bradykinesia0ATP6AP2 CL E G H1015918305OMIM:300911Parkinsonism with spasticity, X-linked.36
HP:0002067HP:0002067Bradykinesia0ATP6AP2 CL E G H1015918305ORPHA:363654X-linked parkinsonism-spasticity syndromeHP:0040282 - Frequent36
HP:0002067HP:0002067Bradykinesia0ATXN1 CL E G H631010548ORPHA:98755Spinocerebellar ataxia type 1HP:0040282 - Frequent19
HP:0002067HP:0002067Bradykinesia0ATXN10 CL E G H2581410549OMIM:603516Spinocerebellar ataxia 109
HP:0002067HP:0002067Bradykinesia0ATXN2 CL E G H631110555OMIM:168600Parkinson disease, late-onset.11
HP:0002067HP:0002067Bradykinesia0ATXN2 CL E G H631110555OMIM:183090Spinocerebellar ataxia 2.11
HP:0002067HP:0002067Bradykinesia0ATXN3 CL E G H42877106OMIM:109150Machado-Joseph disease.14
HP:0002067HP:0002067Bradykinesia0ATXN8 CL E G H72406632925ORPHA:98760Spinocerebellar ataxia type 8HP:0040282 - Frequent1
HP:0002067HP:0002067Bradykinesia0ATXN8OS CL E G H631510561OMIM:168600Parkinson disease, late-onset.1
HP:0002067HP:0002067Bradykinesia0ATXN8OS CL E G H631510561ORPHA:98760Spinocerebellar ataxia type 8HP:0040282 - Frequent1
HP:0002067HP:0002067Bradykinesia0C19ORF12 CL E G H8363625443ORPHA:289560Mitochondrial membrane protein-associated neurodegenerationHP:0040282 - Frequent114
HP:0002067HP:0002067Bradykinesia0CHCHD2 CL E G H5114221645OMIM:616710Parkinson disease 22, autosomal dominant.3
HP:0002067HP:0002067Bradykinesia0CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0002067HP:0002067Bradykinesia0CLTC CL E G H12132092OMIM:617854Mental retardation, autosomal dominant 561
HP:0002067HP:0002067Bradykinesia0COASY CL E G H8034729932OMIM:615643Neurodegeneration with brain iron accumulation 6.16
HP:0002067HP:0002067Bradykinesia0COQ2 CL E G H2723525223OMIM:146500Multiple system atrophy 1, susceptibility to.54
HP:0002067HP:0002067Bradykinesia0COQ2 CL E G H2723525223ORPHA:227510Multiple system atrophy, cerebellar typeHP:0040283 - Occasional54
HP:0002067HP:0002067Bradykinesia0COQ2 CL E G H2723525223ORPHA:98933Multiple system atrophy, parkinsonian typeHP:0040282 - Frequent54
HP:0002067HP:0002067Bradykinesia0CSF1R CL E G H14362433OMIM:221820Leukoencephalopathy, diffuse hereditary, with spheroids.149
HP:0002067HP:0002067Bradykinesia0DCTN1 CL E G H16392711OMIM:168605Perry syndrome.86
HP:0002067HP:0002067Bradykinesia0DHDDS CL E G H7994720603OMIM:617836Developmental delay and seizures with or without movement abnormalities.47
HP:0002067HP:0002067Bradykinesia0DNAJC12 CL E G H5652128908OMIM:617384Hyperphenylalaninemia, MILD, non-bh4-deficient.3
HP:0002067HP:0002067Bradykinesia0DNAJC13 CL E G H2331730343ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional2
HP:0002067HP:0002067Bradykinesia0DNAJC6 CL E G H982915469ORPHA:391411Atypical juvenile parkinsonismHP:0040281 - Very frequent6
HP:0002067HP:0002067Bradykinesia0DNAJC6 CL E G H982915469OMIM:615528Parkinson disease 19a, juvenile-onset.6
HP:0002067HP:0002067Bradykinesia0DNAJC6 CL E G H982915469ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional6
HP:0002067HP:0002067Bradykinesia0EARS2 CL E G H12445429419OMIM:614924Combined oxidative phosphorylation deficiency 12.80
HP:0002067HP:0002067Bradykinesia0EIF2AK1 CL E G H2710224921OMIM:618878LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME; LEMSPAD
HP:0002067HP:0002067Bradykinesia0EIF2AK2 CL E G H56109437OMIM:618877LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME; LEUDEN
HP:0002067HP:0002067Bradykinesia0EIF4G1 CL E G H19813296ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional2
HP:0002067HP:0002067Bradykinesia0EIF4G1 CL E G H19813296OMIM:614251Parkinson disease 18.2
HP:0002067HP:0002067Bradykinesia0FARS2 CL E G H1066721062ORPHA:466722Autosomal recessive spastic paraplegia type 77HP:0040283 - Occasional36
HP:0002067HP:0002067Bradykinesia0FBXO7 CL E G H2579313586OMIM:260300Parkinson disease 15, autosomal recessive early-onset.36
HP:0002067HP:0002067Bradykinesia0FBXO7 CL E G H2579313586ORPHA:171695Parkinsonian-pyramidal syndromeHP:0040282 - Frequent36
HP:0002067HP:0002067Bradykinesia0FMR1 CL E G H23323775OMIM:300623Fragile X tremor/ataxia syndrome30
HP:0002067HP:0002067Bradykinesia0FMR1 CL E G H23323775ORPHA:93256Fragile X-associated tremor/ataxia syndromeHP:0040283 - Occasional30
HP:0002067HP:0002067Bradykinesia0FTL CL E G H25123999OMIM:606159Neurodegeneration with brain iron accumulation 333
HP:0002067HP:0002067Bradykinesia0FTL CL E G H25123999ORPHA:157846NeuroferritinopathyHP:0040282 - Frequent33
HP:0002067HP:0002067Bradykinesia0GABRA1 CL E G H25544075ORPHA:33069Dravet syndromeHP:0040282 - Frequent134
HP:0002067HP:0002067Bradykinesia0GABRD CL E G H25634084ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare10
HP:0002067HP:0002067Bradykinesia0GABRG2 CL E G H25664087ORPHA:33069Dravet syndromeHP:0040282 - Frequent139
HP:0002067HP:0002067Bradykinesia0GABRG2 CL E G H25664087ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare139
HP:0002067HP:0002067Bradykinesia0GBA1 CL E G H26294177ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional
HP:0002067HP:0002067Bradykinesia0GBA1 CL E G H26294177OMIM:168600Parkinson disease, late-onset.
HP:0002067HP:0002067Bradykinesia0GCH1 CL E G H26434193ORPHA:98808Autosomal dominant dopa-responsive dystoniaHP:0040283 - Occasional86
HP:0002067HP:0002067Bradykinesia0GCH1 CL E G H26434193OMIM:128230Dystonia, DOPA-responsive, with or without hyperphenylalaninemia86
HP:0002067HP:0002067Bradykinesia0GIGYF2 CL E G H2605811960ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional8
HP:0002067HP:0002067Bradykinesia0GIGYF2 CL E G H2605811960OMIM:607688PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK118
HP:0002067HP:0002067Bradykinesia0GLUD2 CL E G H27474336OMIM:168600Parkinson disease, late-onset.1
HP:0002067HP:0002067Bradykinesia0HCN1 CL E G H3489804845ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare54
HP:0002067HP:0002067Bradykinesia0HTRA2 CL E G H2742914348OMIM:610297PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK1339
HP:0002067HP:0002067Bradykinesia0HTRA2 CL E G H2742914348ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional39
HP:0002067HP:0002067Bradykinesia0HTT CL E G H30644851OMIM:143100Huntington disease.12
HP:0002067HP:0002067Bradykinesia0HTT CL E G H30644851ORPHA:399Huntington diseaseHP:0040282 - Frequent12
HP:0002067HP:0002067Bradykinesia0HTT CL E G H30644851ORPHA:248111Juvenile Huntington diseaseHP:0040282 - Frequent12
HP:0002067HP:0002067Bradykinesia0HTT CL E G H30644851OMIM:617435Lopes-Maciel-Rodan syndrome.12
HP:0002067HP:0002067Bradykinesia0IMPDH2 CL E G H36156053ORPHA:98808Autosomal dominant dopa-responsive dystoniaHP:0040283 - Occasional1
HP:0002067HP:0002067Bradykinesia0JAM2 CL E G H5849414686OMIM:618824BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE; IBGC8
HP:0002067HP:0002067Bradykinesia0JPH3 CL E G H5733814203OMIM:606438Huntington disease-like 2.2
HP:0002067HP:0002067Bradykinesia0KBTBD13 CL E G H39059437227ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent80
HP:0002067HP:0002067Bradykinesia0KCNC3 CL E G H37486235ORPHA:98768Spinocerebellar ataxia type 13HP:0040284 - Very rare17
HP:0002067HP:0002067Bradykinesia0KCNN2 CL E G H37816291OMIM:619725NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE MOVEMENT OR BEHAVIORAL ABNORMALITIES; NEDMAB
HP:0002067HP:0002067Bradykinesia0KLHL41 CL E G H1032416905ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent13
HP:0002067HP:0002067Bradykinesia0LRRK2 CL E G H12089218618ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional221
HP:0002067HP:0002067Bradykinesia0LRRK2 CL E G H12089218618OMIM:607060Parkinson disease 8, autosomal dominant.221
HP:0002067HP:0002067Bradykinesia0LRRK2 CL E G H12089218618ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional221
HP:0002067HP:0002067Bradykinesia0MAPT CL E G H41376893ORPHA:240071Classic progressive supranuclear palsy syndromeHP:0040282 - Frequent140
HP:0002067HP:0002067Bradykinesia0MAPT CL E G H41376893OMIM:168600Parkinson disease, late-onset.140
HP:0002067HP:0002067Bradykinesia0MAPT CL E G H41376893ORPHA:240103Progressive supranuclear palsy-corticobasal syndromeHP:0040280 - Obligate140
HP:0002067HP:0002067Bradykinesia0MAPT CL E G H41376893ORPHA:240085Progressive supranuclear palsy-parkinsonism syndromeHP:0040282 - Frequent140
HP:0002067HP:0002067Bradykinesia0MAPT CL E G H41376893OMIM:601104Supranuclear palsy, progressive, 1.140
HP:0002067HP:0002067Bradykinesia0MECP2 CL E G H42046990OMIM:300055Mental retardation, X-linked, syndromic 13950
HP:0002067HP:0002067Bradykinesia0MECP2 CL E G H42046990ORPHA:778Rett syndromeHP:0040282 - Frequent950
HP:0002067HP:0002067Bradykinesia0MYORG CL E G H5746219918OMIM:618317Basal ganglia calcification, idiopathic, 7, autosomal recessive.
HP:0002067HP:0002067Bradykinesia0MYPN CL E G H8466523246ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent217
HP:0002067HP:0002067Bradykinesia0NEB CL E G H47037720ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent745
HP:0002067HP:0002067Bradykinesia0NR4A2 CL E G H49297981OMIM:61991127
HP:0002067HP:0002067Bradykinesia0NR4A2 CL E G H49297981ORPHA:98808Autosomal dominant dopa-responsive dystoniaHP:0040283 - Occasional27
HP:0002067HP:0002067Bradykinesia0NR4A2 CL E G H49297981OMIM:168600Parkinson disease, late-onset.27
HP:0002067HP:0002067Bradykinesia0PANK2 CL E G H8002515894OMIM:234200Neurodegeneration with brain iron accumulation 1.55
HP:0002067HP:0002067Bradykinesia0PARK7 CL E G H1131516369OMIM:606324PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK723
HP:0002067HP:0002067Bradykinesia0PARK7 CL E G H1131516369ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional23
HP:0002067HP:0002067Bradykinesia0PCDH19 CL E G H5752614270ORPHA:33069Dravet syndromeHP:0040282 - Frequent225
HP:0002067HP:0002067Bradykinesia0PDE8B CL E G H86228794ORPHA:228169Autosomal dominant striatal neurodegenerationHP:0040281 - Very frequent75
HP:0002067HP:0002067Bradykinesia0PDE8B CL E G H86228794OMIM:609161Striatal degeneration, autosomal dominant.75
HP:0002067HP:0002067Bradykinesia0PDGFB CL E G H51558800OMIM:213600Basal ganglia calcification, idiopathic, 1.9
HP:0002067HP:0002067Bradykinesia0PDGFRB CL E G H51598804OMIM:213600Basal ganglia calcification, idiopathic, 1.28
HP:0002067HP:0002067Bradykinesia0PET117 CL E G H10030375540045OMIM:619063MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19
HP:0002067HP:0002067Bradykinesia0PIDD1 CL E G H5536716491OMIM:619827INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY; MRT75
HP:0002067HP:0002067Bradykinesia0PINK1 CL E G H6501814581OMIM:605909Parkinson disease 6, autosomal recessive early-onset.55
HP:0002067HP:0002067Bradykinesia0PINK1 CL E G H6501814581ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional55
HP:0002067HP:0002067Bradykinesia0PLA2G6 CL E G H83989039ORPHA:199351Adult-onset dystonia-parkinsonismHP:0040282 - Frequent133
HP:0002067HP:0002067Bradykinesia0PLA2G6 CL E G H83989039OMIM:610217Neurodegeneration with brain iron accumulation 2B.133
HP:0002067HP:0002067Bradykinesia0PLA2G6 CL E G H83989039OMIM:612953Parkinson disease 14, autosomal recessive.133
HP:0002067HP:0002067Bradykinesia0PODXL CL E G H54209171ORPHA:391411Atypical juvenile parkinsonismHP:0040281 - Very frequent6
HP:0002067HP:0002067Bradykinesia0PODXL CL E G H54209171ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional6
HP:0002067HP:0002067Bradykinesia0POLG CL E G H54289179ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent464
HP:0002067HP:0002067Bradykinesia0POLG CL E G H54289179ORPHA:254886Autosomal recessive progressive external ophthalmoplegiaHP:0040283 - Occasional464
HP:0002067HP:0002067Bradykinesia0POLG CL E G H54289179OMIM:157640Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1.464
HP:0002067HP:0002067Bradykinesia0POLG CL E G H54289179OMIM:258450Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive.464
HP:0002067HP:0002067Bradykinesia0POLG2 CL E G H112329180ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent45
HP:0002067HP:0002067Bradykinesia0PPP2R2B CL E G H55219305ORPHA:98762Spinocerebellar ataxia type 12HP:0040283 - Occasional5
HP:0002067HP:0002067Bradykinesia0PRDX3 CL E G H109359354OMIM:619862
HP:0002067HP:0002067Bradykinesia0PRKAR1B CL E G H55759390ORPHA:412066PRKAR1B-related neurodegenerative dementia with intermediate filamentsHP:0040282 - Frequent2
HP:0002067HP:0002067Bradykinesia0PRKN CL E G H50718607OMIM:600116Parkinson disease, juvenile, type 2138
HP:0002067HP:0002067Bradykinesia0PRKN CL E G H50718607ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional138
HP:0002067HP:0002067Bradykinesia0PRKRA CL E G H85759438OMIM:612067Dystonia 16.37
HP:0002067HP:0002067Bradykinesia0PRKRA CL E G H85759438ORPHA:210571Dystonia 16HP:0040282 - Frequent37
HP:0002067HP:0002067Bradykinesia0PRNP CL E G H56219449OMIM:137440Gerstmann-Straussler disease.69
HP:0002067HP:0002067Bradykinesia0PRNP CL E G H56219449ORPHA:157941Huntington disease-like 1HP:0040283 - Occasional69
HP:0002067HP:0002067Bradykinesia0PRNP CL E G H56219449ORPHA:282166Inherited Creutzfeldt-Jakob diseaseHP:0040282 - Frequent69
HP:0002067HP:0002067Bradykinesia0PTS CL E G H58059689ORPHA:136-pyruvoyl-tetrahydropterin synthase deficiencyHP:0040283 - Occasional19
HP:0002067HP:0002067Bradykinesia0PTS CL E G H58059689OMIM:261640Hyperphenylalaninemia, BH4-deficient, A.19
HP:0002067HP:0002067Bradykinesia0RAB39B CL E G H11644216499OMIM:311510Waisman syndrome.34
HP:0002067HP:0002067Bradykinesia0RRM2B CL E G H5048417296ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent125
HP:0002067HP:0002067Bradykinesia0SCN1A CL E G H632310585ORPHA:33069Dravet syndromeHP:0040282 - Frequent1053
HP:0002067HP:0002067Bradykinesia0SCN1A CL E G H632310585ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare1053
HP:0002067HP:0002067Bradykinesia0SCN1B CL E G H632410586ORPHA:33069Dravet syndromeHP:0040282 - Frequent126
HP:0002067HP:0002067Bradykinesia0SCN1B CL E G H632410586ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare126
HP:0002067HP:0002067Bradykinesia0SCN2A CL E G H632610588ORPHA:33069Dravet syndromeHP:0040282 - Frequent427
HP:0002067HP:0002067Bradykinesia0SCN2A CL E G H632610588ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare427
HP:0002067HP:0002067Bradykinesia0SCN9A CL E G H633510597ORPHA:33069Dravet syndromeHP:0040282 - Frequent318
HP:0002067HP:0002067Bradykinesia0SCN9A CL E G H633510597ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare318
HP:0002067HP:0002067Bradykinesia0SLC20A2 CL E G H657510947OMIM:213600Basal ganglia calcification, idiopathic, 1.70
HP:0002067HP:0002067Bradykinesia0SLC25A4 CL E G H29110990ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent68
HP:0002067HP:0002067Bradykinesia0SLC2A3 CL E G H651511007ORPHA:399Huntington diseaseHP:0040282 - Frequent1
HP:0002067HP:0002067Bradykinesia0SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndromeHP:0040282 - Frequent42
HP:0002067HP:0002067Bradykinesia0SLC30A10 CL E G H5553225355OMIM:613280Hypermanganesemia with dystonia 142
HP:0002067HP:0002067Bradykinesia0SLC39A14 CL E G H2351620858ORPHA:521406Dystonia-parkinsonism-hypermanganesemia syndromeHP:0040282 - Frequent5
HP:0002067HP:0002067Bradykinesia0SLC39A14 CL E G H2351620858OMIM:617013Hypermanganesemia with dystonia 2.5
HP:0002067HP:0002067Bradykinesia0SLC6A3 CL E G H653111049ORPHA:238455Infantile dystonia-parkinsonismHP:0040282 - Frequent13
HP:0002067HP:0002067Bradykinesia0SLC6A3 CL E G H653111049OMIM:613135Parkinsonism-Dystonia, infantile, 1.13
HP:0002067HP:0002067Bradykinesia0SNCA CL E G H662211138ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional65
HP:0002067HP:0002067Bradykinesia0SNCA CL E G H662211138OMIM:168601Parkinson disease 1, autosomal dominant.65
HP:0002067HP:0002067Bradykinesia0SNCA CL E G H662211138ORPHA:171695Parkinsonian-pyramidal syndromeHP:0040282 - Frequent65
HP:0002067HP:0002067Bradykinesia0SNCA CL E G H662211138ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional65
HP:0002067HP:0002067Bradykinesia0SNCAIP CL E G H962711139OMIM:168600Parkinson disease, late-onset.35
HP:0002067HP:0002067Bradykinesia0SPR CL E G H669711257ORPHA:70594Dopa-responsive dystonia due to sepiapterin reductase deficiencyHP:0040282 - Frequent28
HP:0002067HP:0002067Bradykinesia0STX1B CL E G H11275518539ORPHA:36387Generalized epilepsy with febrile seizures-plusHP:0040284 - Very rare9
HP:0002067HP:0002067Bradykinesia0SYNJ1 CL E G H886711503ORPHA:391411Atypical juvenile parkinsonismHP:0040281 - Very frequent9
HP:0002067HP:0002067Bradykinesia0SYNJ1 CL E G H886711503OMIM:615530Parkinson disease 20, early-onset.9
HP:0002067HP:0002067Bradykinesia0SYNJ1 CL E G H886711503ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional9
HP:0002067HP:0002067Bradykinesia0TACO1 CL E G H5120424316OMIM:619052MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8; MC4DN823
HP:0002067HP:0002067Bradykinesia0TAF1 CL E G H687211535ORPHA:53351X-linked dystonia-parkinsonismHP:0040282 - Frequent21
HP:0002067HP:0002067Bradykinesia0TBP CL E G H690811588OMIM:168600Parkinson disease, late-onset.7
HP:0002067HP:0002067Bradykinesia0TBP CL E G H690811588OMIM:607136Spinocerebellar ataxia 17.7
HP:0002067HP:0002067Bradykinesia0TH CL E G H705411782ORPHA:101150Autosomal recessive dopa-responsive dystoniaHP:0040282 - Frequent80
HP:0002067HP:0002067Bradykinesia0TK2 CL E G H708411831ORPHA:254886Autosomal recessive progressive external ophthalmoplegiaHP:0040283 - Occasional103
HP:0002067HP:0002067Bradykinesia0TPM2 CL E G H716912011ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent54
HP:0002067HP:0002067Bradykinesia0TPM3 CL E G H717012012ORPHA:171439Childhood-onset nemaline myopathyHP:0040282 - Frequent108
HP:0002067HP:0002067Bradykinesia0TRNT CL E G H45767499OMIM:168600Parkinson disease, late-onset.
HP:0002067HP:0002067Bradykinesia0TSPOAP1 CL E G H925616831ORPHA:101150Autosomal recessive dopa-responsive dystoniaHP:0040282 - Frequent2
HP:0002067HP:0002067Bradykinesia0TTC19 CL E G H5490226006OMIM:615157Mitochondrial complex III deficiency, nuclear type 2.88
HP:0002067HP:0002067Bradykinesia0TWNK CL E G H566521160ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040282 - Frequent113
HP:0002067HP:0002067Bradykinesia0UCHL1 CL E G H734512513OMIM:613643PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK521
HP:0002067HP:0002067Bradykinesia0UCHL1 CL E G H734512513ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional21
HP:0002067HP:0002067Bradykinesia0UQCRC1 CL E G H738412585OMIM:619279PARKINSONISM WITH POLYNEUROPATHY; PKNPY
HP:0002067HP:0002067Bradykinesia0VPS13A CL E G H232301908ORPHA:2388ChoreoacanthocytosisHP:0040283 - Occasional130
HP:0002067HP:0002067Bradykinesia0VPS13C CL E G H5483223594ORPHA:2828Young-onset Parkinson diseaseHP:0040283 - Occasional8
HP:0002067HP:0002067Bradykinesia0VPS35 CL E G H5573713487ORPHA:411602Hereditary late-onset Parkinson diseaseHP:0040283 - Occasional37
HP:0002067HP:0002067Bradykinesia0VPS35 CL E G H5573713487OMIM:614203Parkinson disease 17.37
HP:0002067HP:0002067Bradykinesia0WDR45 CL E G H1115228912ORPHA:329284Beta-propeller protein-associated neurodegenerationHP:0040282 - Frequent51
HP:0002067HP:0002067Bradykinesia0WDR45 CL E G H1115228912OMIM:300894Neurodegeneration with brain iron accumulation 5.51


Genes (112) :ACTA1 ADGRV1 ADH1C ATL1 ATP13A2 ATP1A3 ATP5MK ATP6AP2 ATXN1 ATXN10 ATXN2 ATXN3 ATXN8 ATXN8OS C19ORF12 CHCHD2 CLN3 CLTC COASY COQ2 CSF1R DCTN1 DHDDS DNAJC12 DNAJC13 DNAJC6 EARS2 EIF2AK1 EIF2AK2 EIF4G1 FARS2 FBXO7 FMR1 FTL GABRA1 GABRD GABRG2 GBA1 GCH1 GIGYF2 GLUD2 HCN1 HTRA2 HTT IMPDH2 JAM2 JPH3 KBTBD13 KCNC3 KCNN2 KLHL41 LRRK2 MAPT MECP2 MYORG MYPN NEB NR4A2 PANK2 PARK7 PCDH19 PDE8B PDGFB PDGFRB PET117 PIDD1 PINK1 PLA2G6 PODXL POLG POLG2 PPP2R2B PRDX3 PRKAR1B PRKN PRKRA PRNP PTS RAB39B RRM2B SCN1A SCN1B SCN2A SCN9A SLC20A2 SLC25A4 SLC2A3 SLC30A10 SLC39A14 SLC6A3 SNCA SNCAIP SPR STX1B SYNJ1 TACO1 TAF1 TBP TH TK2 TPM2 TPM3 TRNT TSPOAP1 TTC19 TWNK UCHL1 UQCRC1 VPS13A VPS13C VPS35 WDR45

Diseases (116) :ORPHA:171439 ORPHA:36387 OMIM:168600 ORPHA:100984 ORPHA:314632 OMIM:606693 ORPHA:306674 OMIM:617225 OMIM:601338 OMIM:128235 ORPHA:71517 OMIM:618683 OMIM:300423 OMIM:300911 ORPHA:363654 ORPHA:98755 OMIM:603516 OMIM:183090 OMIM:109150 ORPHA:98760 ORPHA:289560 OMIM:616710 ORPHA:228346 OMIM:617854 OMIM:615643 OMIM:146500 ORPHA:227510 ORPHA:98933 OMIM:221820 OMIM:168605 OMIM:617836 OMIM:617384 ORPHA:411602 ORPHA:391411 OMIM:615528 ORPHA:2828 OMIM:614924 OMIM:618878 OMIM:618877 OMIM:614251 ORPHA:466722 OMIM:260300 ORPHA:171695 OMIM:300623 ORPHA:93256 OMIM:606159 ORPHA:157846 ORPHA:33069 ORPHA:98808 OMIM:128230 OMIM:607688 OMIM:610297 OMIM:143100 ORPHA:399 ORPHA:248111 OMIM:617435 OMIM:618824 OMIM:606438 ORPHA:98768 OMIM:619725 OMIM:607060 ORPHA:240071 ORPHA:240103 ORPHA:240085 OMIM:601104 OMIM:300055 ORPHA:778 OMIM:618317 OMIM:619911 OMIM:234200 OMIM:606324 ORPHA:228169 OMIM:609161 OMIM:213600 OMIM:619063 OMIM:619827 OMIM:605909 ORPHA:199351 OMIM:610217 OMIM:612953 ORPHA:254892 ORPHA:254886 OMIM:157640 OMIM:258450 ORPHA:98762 OMIM:619862 ORPHA:412066 OMIM:600116 OMIM:612067 ORPHA:210571 OMIM:137440 ORPHA:157941 ORPHA:282166 ORPHA:13 OMIM:261640 OMIM:311510 ORPHA:309854 OMIM:613280 ORPHA:521406 OMIM:617013 ORPHA:238455 OMIM:613135 OMIM:168601 ORPHA:70594 OMIM:615530 OMIM:619052 ORPHA:53351 OMIM:607136 ORPHA:101150 OMIM:615157 OMIM:613643 OMIM:619279 ORPHA:2388 OMIM:614203 ORPHA:329284 OMIM:300894
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.